Text Size

Hypertrophic Scarring After Facial Burn

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2007 by Legacy Health System.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Total Contact
Information provided by:
Legacy Health System
ClinicalTrials.gov Identifier:
NCT00242970
First received: October 20, 2005
Last updated: April 10, 2007
Last verified: April 2007
History of Changes
  Purpose

Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.


Condition Intervention Phase
Burn
 Device: Cyberware 3030 RGB Color Scanner
 Phase 2

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Hypertrophic Scarring After Facial Burn: A Pilot, Observational Study of Static and Dynamic Measurements of Facial Scars With the 3-D Scanner Through the Scar Maturation Process

Resource links provided by NLM:

MedlinePlus related topics: Burns Scars
U.S. FDA Resources

Further study details as provided by Legacy Health System:

Estimated Enrollment: 15
Study Start Date: October 2005
Estimated Study Completion Date: July 2008
Detailed Description:

Subjects will have 11 clinic visits over a 2-year period. An initial scan of the subject's head and neck will be made. Ten reproducible landmarks on the face and neck will be determined. The subject will return for follow up scans at Day 14, Day 28 and Month 2,6,9,12,18 and 24.

  Eligibility

Ages Eligible for Study:   4 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Face and/or Neck Burn
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00242970

Contacts
Contact: Lorraine Donison, RN 503 413-7945 ldonison@lhs.org

Locations
United States, Oregon
Legacy Emanuel Hospital and Health Center Recruiting
Portland, Oregon, United States, 97227
Principal Investigator: Helen Christians, OTR/L            
Sponsors and Collaborators
Legacy Health System
Total Contact
Investigators
Principal Investigator: Helen Christians, ORT/L Legacy Health System
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00242970     History of Changes
Other Study ID Numbers: OBC3DS-01
Study First Received: October 20, 2005
Last Updated: April 10, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Burns
Cicatrix
Hypertrophy
Cicatrix, Hypertrophic
 Wounds and Injuries
Fibrosis
Pathologic Processes
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on May 19, 2013